This week’s update highlights important legislative advancements in Illinois, Utah, South Dakota, and Kentucky, focuses on upcoming hearings, and provides updates on several other important bills moving forward across the country.
Year: 2022
With a vote of 59 to 34, members of the Kentucky House of Representatives have advanced House Bill 136 to the Senate for further consideration. The bill provides for the production and distribution of a limited variety of medical cannabis products to qualified patients, including those with PTSD, cancer, chronic pain, epilepsy or any other intractable seizure disorder; multiple sclerosis, muscle spasms, or spasticity; and nausea or vomiting.
“The attitudes and priorities of federal prosecutors have shifted in the era of state-level marijuana legalization.”
A robust, above-ground retail marijuana market is necessary in order to disrupt the unregulated marketplace and to assure that consumers have adequate access to lab-tested, high quality products at competitive prices.
Last week, Delaware’s House of Representatives missed another chance to legalize cannabis for adults 21 and older. HB 305 needed to clear a legislative hurdle requiring a three–fifths super majority, or 25 votes. The final tally on March 10th was 23-14-4.
The new rules stipulate, “No person currently employed by St. Louis County or applying for employment by St. Louis County shall be required to undergo pre-employment or random drug testing for the presence of marijuana metabolites (THC) as a condition or part of employment.”
This week’s update highlights important legalization advancements in Delaware and in Pennsylvania as well as updates on several other important bills moving forward across the country.
Despite a majority of lawmakers who participated in the vote deciding in favor of the measure, it failed to garner the required 3/5 supermajority to advance to the Senate.